Nanda Gamad

654 total citations
15 papers, 519 citations indexed

About

Nanda Gamad is a scholar working on Pathology and Forensic Medicine, Complementary and alternative medicine and Surgery. According to data from OpenAlex, Nanda Gamad has authored 15 papers receiving a total of 519 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 3 papers in Complementary and alternative medicine and 2 papers in Surgery. Recurrent topics in Nanda Gamad's work include Chemotherapy-induced organ toxicity mitigation (3 papers), Biomedical Research and Pathophysiology (2 papers) and Cardiac Ischemia and Reperfusion (2 papers). Nanda Gamad is often cited by papers focused on Chemotherapy-induced organ toxicity mitigation (3 papers), Biomedical Research and Pathophysiology (2 papers) and Cardiac Ischemia and Reperfusion (2 papers). Nanda Gamad collaborates with scholars based in India, United Arab Emirates and Jordan. Nanda Gamad's co-authors include Kapil Suchal, Salma Malik, Jagriti Bhatia, Dharamvir Singh Arya, Amit Kumar Dinda, Sameer N. Goyal, Rajiv Malhotra, Shreesh Ojha, Uma Chaudhary and Sudheer Arava and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Journal of Pharmacology and Frontiers in Pharmacology.

In The Last Decade

Nanda Gamad

13 papers receiving 513 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nanda Gamad India	8	162	152	122	75	57	15	519
Sara Hosseinian Iran	14	112 0.7×	108 0.7×	107 0.9×	86 1.1×	88 1.5×	39	498
Marwa M. Khalaf Egypt	14	212 1.3×	235 1.5×	73 0.6×	67 0.9×	127 2.2×	42	714
Iman O. Sherif Egypt	16	240 1.5×	187 1.2×	87 0.7×	54 0.7×	101 1.8×	29	673
Rajiv Malhotra India	14	120 0.7×	188 1.2×	158 1.3×	42 0.6×	55 1.0×	28	701
Ebtehal El‐Demerdash Egypt	15	278 1.7×	195 1.3×	59 0.5×	63 0.8×	57 1.0×	25	771
Aziz Karaoğlu Türkiye	11	354 2.2×	174 1.1×	77 0.6×	101 1.3×	69 1.2×	47	966
Mohamed M. Elseweidy Egypt	17	78 0.5×	138 0.9×	54 0.4×	66 0.9×	80 1.4×	57	826
Hebatallah Husseini Atteia Egypt	16	93 0.6×	140 0.9×	52 0.4×	93 1.2×	71 1.2×	44	721
Ruma Ray India	12	81 0.5×	190 1.3×	91 0.7×	50 0.7×	30 0.5×	16	499
Ola M. Abd El‐Raouf Egypt	12	142 0.9×	87 0.6×	41 0.3×	58 0.8×	71 1.2×	17	442

Countries citing papers authored by Nanda Gamad

Since Specialization

Citations

This map shows the geographic impact of Nanda Gamad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nanda Gamad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nanda Gamad more than expected).

Fields of papers citing papers by Nanda Gamad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nanda Gamad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nanda Gamad. The network helps show where Nanda Gamad may publish in the future.

Co-authorship network of co-authors of Nanda Gamad

This figure shows the co-authorship network connecting the top 25 collaborators of Nanda Gamad. A scholar is included among the top collaborators of Nanda Gamad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nanda Gamad. Nanda Gamad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Kumar, Ankit, et al.. (2023). Dose-dependent renoprotection efficacy of sglt2 inhibitors in type 2 diabetes: systematic review and network meta-analysis. Acta Diabetologica. 60(10). 1311–1331. 2 indexed citations

Mohindra, Ritin, Ankit Kumar, Swati Sharma, et al.. (2022). Essential oil nebulization in mild COVID-19(EONCO): Early phase exploratory clinical trial. Journal of Ayurveda and Integrative Medicine. 13(3). 100626–100626. 5 indexed citations

Kumar, Ankit, et al.. (2022). Comparison of master two-step exercise stress test versus six-min walk test in patients tested positive for SARS-CoV-2. SHILAP Revista de lepidopterología. 11(11). 7008–7014.

Pandey, Avaneesh Kumar, et al.. (2022). Physical therapy intervention versus corticosteroid injection for lateral elbow tendinopathy. Does slow and steady win the race? – A systematic review. Shoulder & Elbow. 16(1_suppl). 59–73. 2 indexed citations

Gamad, Nanda, Pradip Kumar Saha, Prashant Sharma, et al.. (2021). A randomized controlled trial comparing the efficacy, tolerability, and cost of oral iron preparations in iron‐deficiency anemia in pregnancy. Journal of obstetrics and gynaecology research. 47(11). 3828–3841. 7 indexed citations

Kakkar, Ashish Kumar, Nusrat Shafiq, Ritin Mohindra, et al.. (2021). Assessment of Appropriateness of Antimicrobial Therapy in Resource-Constrained Settings: Development and Piloting of a Novel Tool—AmRAT. Antibiotics. 10(2). 200–200. 4 indexed citations

Gamad, Nanda, Nusrat Shafiq, & Samir Malhotra. (2020). Meta-analysis of cardiovascular superiority trials published in theNew England Journal of Medicineto elucidate the concept of superiority margin. Postgraduate Medical Journal. 97(1146). 227–233.

Gamad, Nanda, Salma Malik, Kapil Suchal, et al.. (2017). Metformin alleviates bleomycin-induced pulmonary fibrosis in rats: Pharmacological effects and molecular mechanisms. Biomedicine & Pharmacotherapy. 97. 1544–1553. 61 indexed citations

Suchal, Kapil, Jagriti Bhatia, Salma Malik, et al.. (2016). Seabuckthorn Pulp Oil Protects against Myocardial Ischemia–Reperfusion Injury in Rats through Activation of Akt/eNOS. Frontiers in Pharmacology. 7. 155–155. 19 indexed citations

10.

Malik, Salma, Kapil Suchal, Jagriti Bhatia, et al.. (2016). Molecular mechanisms underlying attenuation of cisplatin-induced acute kidney injury by epicatechin gallate. Laboratory Investigation. 96(8). 853–861. 32 indexed citations

11.

Suchal, Kapil, Salma Malik, Nanda Gamad, et al.. (2016). Mangiferin protect myocardial insults through modulation of MAPK/TGF-β pathways. European Journal of Pharmacology. 776. 34–43. 46 indexed citations

12.

Suchal, Kapil, Salma Malik, Nanda Gamad, et al.. (2016). Kaempferol Attenuates Myocardial Ischemic Injury via Inhibition of MAPK Signaling Pathway in Experimental Model of Myocardial Ischemia‐Reperfusion Injury. Oxidative Medicine and Cellular Longevity. 2016(1). 7580731–7580731. 93 indexed citations

13.

Suchal, Kapil, Salma Malik, Nanda Gamad, et al.. (2016). Kampeferol protects against oxidative stress and apoptotic damage in experimental model of isoproterenol-induced cardiac toxicity in rats. Phytomedicine. 23(12). 1401–1408. 72 indexed citations

14.

Malik, Salma, Jagriti Bhatia, Kapil Suchal, et al.. (2015). Nobiletin ameliorates cisplatin-induced acute kidney injury due to its anti-oxidant, anti-inflammatory and anti-apoptotic effects. Experimental and Toxicologic Pathology. 67(7-8). 427–433. 73 indexed citations

15.

Malik, Salma, Kapil Suchal, Nanda Gamad, et al.. (2014). Telmisartan ameliorates cisplatin-induced nephrotoxicity by inhibiting MAPK mediated inflammation and apoptosis. European Journal of Pharmacology. 748. 54–60. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact